ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726432 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726432; 2) Community: the network communities that were significantly associated with the response to NSC 726432; 3) Molecule: the relationships between components within communities and NSC 726432; 4) MDR: the compounds that were significantly associated with the NSC 726432.

NSC Compound Enrichment Correlation
NSC 606985 Camptothecin Derivative 0.00012706483944704 0.10395222
NSC 616348 Irinotecan hydrochloride 0.00012706483944704 0.31316221
NSC 618939 Camptothecin Derivative 0.00012706483944704 0.16110598
NSC 646127 6H-Pyrido[4,3-b]carbazole, 1,2-dihydro-2,5,9,11-tetra- methyl- 0.00012706483944704 -0.13471771
NSC 725775 6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 0.00012706483944704 0.1389778
NSC 735037 Camptothecin Derivative 0.000127064839447042 0.16505561
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.000127064839447042 0.17327769
NSC 375162 Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide 0.000177788864158557 0.42934258
NSC 697726 RH1 0.000177788864158557 0.27193033
NSC 726332 6-[3-((2,2-Dimethoxyethylamino)-1-propyl)]-5,6-dihydro-2,3- dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c] isoquinoline 0.000190877555957481 0.377796
Total:78  Current:1    [First] [Prev] [Next] [Last]